These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 1544174)
1. Serum opsonins and liposomes: their interaction and opsonophagocytosis. Patel HM Crit Rev Ther Drug Carrier Syst; 1992; 9(1):39-90. PubMed ID: 1544174 [TBL] [Abstract][Full Text] [Related]
2. Opsonophagocytosis of liposomes by peritoneal macrophages and bone marrow reticuloendothelial cells. Moghimi SM; Patel HM Biochim Biophys Acta; 1992 Jun; 1135(3):269-74. PubMed ID: 1623013 [TBL] [Abstract][Full Text] [Related]
3. The role of immunoproteins in the survival of liposomes in the circulation. Devine DV; Marjan JM Crit Rev Ther Drug Carrier Syst; 1997; 14(2):105-31. PubMed ID: 9107519 [TBL] [Abstract][Full Text] [Related]
4. Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes. Moghimi SM; Patel HM Biochim Biophys Acta; 1989 Sep; 984(3):384-7. PubMed ID: 2775784 [TBL] [Abstract][Full Text] [Related]
5. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus. Butko P; Nicholson-Weller A; Wessels MR J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019 [TBL] [Abstract][Full Text] [Related]
6. Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Harashima H; Sakata K; Funato K; Kiwada H Pharm Res; 1994 Mar; 11(3):402-6. PubMed ID: 8008707 [TBL] [Abstract][Full Text] [Related]
7. Antibodies and thermolabile opsonins in the phagocytosis of human red and white blood cells pretreated with formaldehyde. Nickolov C; Buckureshtliev A; Tsvetkov T; Minchev M; Milev A; Alexiev N; Tsonev L Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(1):43-9. PubMed ID: 6202598 [TBL] [Abstract][Full Text] [Related]
8. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria. Ben Nasr A; Haithcoat J; Masterson JE; Gunn JS; Eaves-Pyles T; Klimpel GR J Leukoc Biol; 2006 Oct; 80(4):774-86. PubMed ID: 16857732 [TBL] [Abstract][Full Text] [Related]
9. Activities of specific cell constituents in phagocytosis (endocytosis). Simson JV; Spicer SS Int Rev Exp Pathol; 1973; 12():79-118. PubMed ID: 4573098 [No Abstract] [Full Text] [Related]
10. Serum factors and the reticuloendothelial uptake of Staphylococcus aureus. I. The role of whole serum. Koenig MG; Melly MA; Goodman JS; Rogers DE J Immunol; 1968 Mar; 100(3):516-24. PubMed ID: 5643075 [No Abstract] [Full Text] [Related]
14. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis. Holzer TJ; Edwards KM; Gewurz H; Mold C J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291 [TBL] [Abstract][Full Text] [Related]
15. Hydrazinonicotinamide prolongs quantum dot circulation and reduces reticuloendothelial system clearance by suppressing opsonization and phagocyte engulfment. Jung KH; Park JW; Paik JY; Lee EJ; Choe YS; Lee KH Nanotechnology; 2012 Dec; 23(49):495102. PubMed ID: 23149806 [TBL] [Abstract][Full Text] [Related]
16. Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes. Moghimi SM; Patel HM FEBS Lett; 1988 Jun; 233(1):143-7. PubMed ID: 3384086 [TBL] [Abstract][Full Text] [Related]
17. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera. Håkansson L; Hällgren R; Venge P Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589 [TBL] [Abstract][Full Text] [Related]
18. Shielding Therapeutic Drug Carriers from the Mononuclear Phagocyte System: A Review. Sathyamoorthy N; Dhanaraju MD Crit Rev Ther Drug Carrier Syst; 2016; 33(6):489-567. PubMed ID: 27992308 [TBL] [Abstract][Full Text] [Related]
19. Parameters influencing the stealthiness of colloidal drug delivery systems. Vonarbourg A; Passirani C; Saulnier P; Benoit JP Biomaterials; 2006 Aug; 27(24):4356-73. PubMed ID: 16650890 [TBL] [Abstract][Full Text] [Related]